SEC Form 4 · accession 0001209191-17-066068
ADURO BIOTECH, INC. · ADRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrea van Elsas
Officer — Chief Scientific Officer
Period of report
Dec 11, 2017
Accepted (ET)
Dec 15, 2017 · 8:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001435049
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 11, 2017 | A | 4,650 | $0.00 | A | 207,231 | D | |
| Common StockF2 | Dec 11, 2017 | A | 16,312 | $0.00 | A | 223,543 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents grant of restricted stock units payable in common stock that vest in four equal annual installments from September 12, 2017.
- F2Represents grant of restricted stock units payable in common stock that vest in four equal annual installments from the grant date of December 11, 2017.